EVOK: Evoke Pharma Inc. Stocks News on July 27, 2024

EVOK

GlobeNewswire

a month ago

Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI

EVOK

GlobeNewswire

2 months ago

Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference

EVOK

GlobeNewswire

2 months ago

Evoke Pharma Reports First Quarter 2024 Financial Results

EVOK

GlobeNewswire

3 months ago

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications

EVOK

GlobeNewswire

4 months ago

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer

EVOK

Simply Wall St.

4 months ago

Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?

EVOK

Insider Monkey

4 months ago

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript

EVOK

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Evoke Pharma Inc Earnings Call

EVOK

GlobeNewswire

4 months ago

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

EVOK

GlobeNewswire

5 months ago

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024

EVOK

GlobeNewswire

5 months ago

Evoke Pharma Announces Closing of $7.5 Million Public Offering

EVOK

GlobeNewswire

6 months ago

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million

EpicQuest Education Announces Bold Strategy as it Hosts the World Cup Argentina Soccer Team Led by Lionel Messi for a Major Revenue Boost

EVOK

PR Newswire

6 months ago

EpicQuest Education Announces Bold Strategy as it Hosts the World Cup Argentina Soccer Team Led by Lionel Messi for a Major Revenue Boost

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

EVOK

GlobeNewswire

6 months ago

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

EVOK

GlobeNewswire

6 months ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

FibroGen, Inc. (NASDAQ:FGEN) institutional owners may be pleased with recent gains after 96% loss over the past year

EVOK

Simply Wall St.

6 months ago

FibroGen, Inc. (NASDAQ:FGEN) institutional owners may be pleased with recent gains after 96% loss over the past year

Regis to Issue Second Quarter Fiscal 2024 Results on January 31, 2024

EVOK

Business Wire

6 months ago

Regis to Issue Second Quarter Fiscal 2024 Results on January 31, 2024

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

EVOK

GlobeNewswire

6 months ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

EVOK

Business Wire

6 months ago

Oragenics Announces Termination of At-The-Market Offering Program

Western New England Bancorp (WNEB) Lags Q4 Earnings Estimates

EVOK

Zacks

6 months ago

Western New England Bancorp (WNEB) Lags Q4 Earnings Estimates

EVOK

Associated Press Finance

6 months ago

Western New England Bancorp: Q4 Earnings Snapshot

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

EVOK

GlobeNewswire

6 months ago

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

Golden Minerals Begins Mining Operations at Velardeña Silver-Gold Properties

EVOK

Business Wire

6 months ago

Golden Minerals Begins Mining Operations at Velardeña Silver-Gold Properties

SurgePays Announces Closing of $15 Million Public Offering

EVOK

GlobeNewswire

6 months ago

SurgePays Announces Closing of $15 Million Public Offering

Score a Free Haircut with Supercuts High Score Promotion

EVOK

PR Newswire

6 months ago

Score a Free Haircut with Supercuts High Score Promotion

Lightbridge Announces Upcoming Industry Event and Media Interview

EVOK

GlobeNewswire

6 months ago

Lightbridge Announces Upcoming Industry Event and Media Interview

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

EVOK

NewMediaWire

6 months ago

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend

EVOK

GlobeNewswire

6 months ago

Kentucky First Federal Bancorp Announces Suspension of Quarterly Cash Dividend

LM Funding Invests in S21 Bitmain Mining Machines in Advance of 2024 Bitcoin Halving Event

EVOK

GlobeNewswire

6 months ago

LM Funding Invests in S21 Bitmain Mining Machines in Advance of 2024 Bitcoin Halving Event

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

EVOK

Zacks

6 months ago

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

EVOK

Motley Fool

6 months ago

Canoo's Warning-Sign Move That Might Lead to a Big Payday for Investors

Spectaire Launches into European Trucking Market with Signed Distribution Agreement

EVOK

CNW Group

6 months ago

Spectaire Launches into European Trucking Market with Signed Distribution Agreement

$Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients$

EVOK

GlobeNewswire

7 months ago

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications

EVOK

GlobeNewswire

7 months ago

SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

EVOK

Simply Wall St.

7 months ago

Investors in Virco Mfg (NASDAQ:VIRC) have seen enviable returns of 413% over the past three years

EVOK

Business Wire

7 months ago

Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance

EVOK

Business Wire

7 months ago

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance

JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

EVOK

PR Newswire

7 months ago

JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami

EVOK

PR Newswire

7 months ago

Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami

Chenghe Acquisition I Co. Receives Nasdaq Notice Regarding Late Form 10-Q Filings

EVOK

PR Newswire

7 months ago

Chenghe Acquisition I Co. Receives Nasdaq Notice Regarding Late Form 10-Q Filings

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

EVOK

Simply Wall St.

7 months ago

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

Best Momentum Stocks to Buy for December 19th

EVOK

Zacks

7 months ago

Best Momentum Stocks to Buy for December 19th

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

EVOK

GlobeNewswire

7 months ago

Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations

EVOK

Reuters

7 months ago

Chinese wealth manager Hywin to offer resolution plans after missed payments

Is Crexendo, Inc. (NASDAQ:CXDO) Trading At A 48% Discount?

EVOK

Simply Wall St.

7 months ago

Is Crexendo, Inc. (NASDAQ:CXDO) Trading At A 48% Discount?

AG Mortgage Investment Trust, Inc. Announces Fourth Quarter 2023 Common Dividend

EVOK

Business Wire

7 months ago

AG Mortgage Investment Trust, Inc. Announces Fourth Quarter 2023 Common Dividend

EVOK

PR Newswire

7 months ago

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS

Aesthetic Medical International Announces Change of Auditor and Change of Director

EVOK

GlobeNewswire

7 months ago

Aesthetic Medical International Announces Change of Auditor and Change of Director

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

EVOK

ACCESSWIRE

8 months ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

ChoiceOne Financial Services, Inc. (NASDAQ:COFS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

EVOK

Simply Wall St.

8 months ago

ChoiceOne Financial Services, Inc. (NASDAQ:COFS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

EVOK

GlobeNewswire

8 months ago

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

EVOK

GlobeNewswire

8 months ago

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

IBN Coverage Initiated for Turbo Energy S.A.

EVOK

GlobeNewswire

8 months ago

IBN Coverage Initiated for Turbo Energy S.A.

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

EVOK

PR Newswire

8 months ago

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

EVOK

PR Newswire

8 months ago

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

EVOK

Business Wire

8 months ago

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

Trevena Awarded OLINVYK Agreement with Premier, Inc.

EVOK

GlobeNewswire

8 months ago

Trevena Awarded OLINVYK Agreement with Premier, Inc.

EVOK

PR Newswire

8 months ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

EVOK

News Direct

8 months ago

Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray

Senstar Technologies Reports Third Quarter 2023 Financial Results

EVOK

PR Newswire

8 months ago

Senstar Technologies Reports Third Quarter 2023 Financial Results

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

EVOK

GlobeNewswire

8 months ago

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

CPS Technologies Corporation to Participate in Virtual Investor Summit on December 7, 2023

EVOK

GlobeNewswire

8 months ago

CPS Technologies Corporation to Participate in Virtual Investor Summit on December 7, 2023

Here's Why We Think Art's-Way Manufacturing (NASDAQ:ARTW) Is Well Worth Watching

EVOK

Simply Wall St.

8 months ago

Here's Why We Think Art's-Way Manufacturing (NASDAQ:ARTW) Is Well Worth Watching

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

EVOK

GlobeNewswire

8 months ago

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

EVOK

GlobeNewswire

8 months ago

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

EVOK

ACCESSWIRE

8 months ago

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

EVOK

PR Newswire

8 months ago

Jowell Global Ltd. Announces First Half 2023 Unaudited Financial Results

Remembering Board Member Chris Stratton: A Tribute to His Legacy and Contributions

EVOK

Business Wire

8 months ago

Remembering Board Member Chris Stratton: A Tribute to His Legacy and Contributions

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock

EVOK

Zacks

8 months ago

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock

Fusion Fuel Announces Third Quarter 2023 Webcast Date

EVOK

GlobeNewswire

8 months ago

Fusion Fuel Announces Third Quarter 2023 Webcast Date

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript

EVOK

Insider Monkey

8 months ago

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

EVOK

ACCESSWIRE

8 months ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

EVOK

GlobeNewswire

8 months ago

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

EVOK

GlobeNewswire

8 months ago

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

EVOK

PR Newswire

8 months ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Retail investors who hold 57% of ICZOOM Group Inc. (NASDAQ:IZM) gained 13%, insiders profited as well

EVOK

Simply Wall St.

8 months ago

Retail investors who hold 57% of ICZOOM Group Inc. (NASDAQ:IZM) gained 13%, insiders profited as well

Jowell Global Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Rule

EVOK

PR Newswire

8 months ago

Jowell Global Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Rule

180 Degree Capital Corp. Establishes Discount Management Program And Reports Net Asset Value Per Share (“Nav”) Of $4.91, Comprised Of 97% Cash And Public Securities, As Of September 30, 2023

EVOK

GlobeNewswire

8 months ago

180 Degree Capital Corp. Establishes Discount Management Program And Reports Net Asset Value Per Share (“Nav”) Of $4.91, Comprised Of 97% Cash And Public Securities, As Of September 30, 2023

PaySign, Inc. (NASDAQ:PAYS) Q3 2023 Earnings Call Transcript

EVOK

Insider Monkey

8 months ago

PaySign, Inc. (NASDAQ:PAYS) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

EVOK

Insider Monkey

8 months ago

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Declining Stock and Solid Fundamentals: Is The Market Wrong About Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

EVOK

Simply Wall St.

8 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

EVOK

Associated Press Finance

9 months ago

Oragenics: Q3 Earnings Snapshot

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

EVOK

GlobeNewswire

9 months ago

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Energy Focus, Inc. Reports Third Quarter 2023 Financial Results

EVOK

News Direct

9 months ago

Energy Focus, Inc. Reports Third Quarter 2023 Financial Results

180 Degree Capital Corp. to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023, and to Host a Conference Call on Tuesday, November 14, 2023

EVOK

GlobeNewswire

9 months ago

180 Degree Capital Corp. to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023, and to Host a Conference Call on Tuesday, November 14, 2023

EVOK

GlobeNewswire

9 months ago

Evoke Pharma Reports Third Quarter 2023 Financial Results

Healthcare Triangle to Host Sessions on Digital Transformation and Ransomware Preparedness for Healthcare Systems at CHIME23 Fall Forum

EVOK

GlobeNewswire

9 months ago

Healthcare Triangle to Host Sessions on Digital Transformation and Ransomware Preparedness for Healthcare Systems at CHIME23 Fall Forum

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

EVOK

GlobeNewswire

9 months ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Inseego Corp. (NASDAQ:INSG) Analysts Are Reducing Their Forecasts For Next Year

EVOK

Simply Wall St.

9 months ago

Inseego Corp. (NASDAQ:INSG) Analysts Are Reducing Their Forecasts For Next Year

EVOK

GuruFocus.com

9 months ago

Alpha Pro Tech Ltd (APT) Reports Strong Earnings Growth in Q3 2023

Alpha Pro Tech, Ltd. Announces Third Quarter 2023 Financial Results

EVOK

GlobeNewswire

9 months ago

Alpha Pro Tech, Ltd. Announces Third Quarter 2023 Financial Results

Gold Resource Corp (GORO) Reports Q3 Operational Results Amidst Strategic Review

EVOK

GuruFocus.com

9 months ago

Gold Resource Corp (GORO) Reports Q3 Operational Results Amidst Strategic Review

EVOK

ETF Database

9 months ago

John Hancock Investment Management Expands ETF Lineup

EVOK

Newsfile

9 months ago

Latest Evoke Pharma Inc. (EVOK) News on July 27, 2024

Share on Social Networks: